Haleos Labs Limited (HALEOSLABS) Share Price & AI Investment Analysis

Haleos Labs Limited engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India. The company offers API and intermediates in areas, such as anti-ulcer, anti-migraine, anti-hypertensive, erectile dysfunction, anti-cancer, antifungal, anti-obesity, anti-emetic, anti-depressant, anti-worm, anti-infective, anti-gout, anti-convulsant, antiviral, and anesthesia, as well as antihistamine, diuretics, hair loss, and ophthalmic API products. It also export its products. The company was formerly known as SMS Lifesciences India Limited and changed its name to Haleos. Track Haleos Labs Limited's live NSE:HALEOSLABS share price ₹1,500.00 (+0.83%), market cap ₹₹5B, P/E 28.7. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for HALEOSLABS — real-time NSE India stock intelligence.